{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:50:28Z","timestamp":1773939028656,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12149-024-01974-w","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:02:51Z","timestamp":1724929371000},"page":"31-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Voxel-based dosimetry with integrated Y-90 PET\/MRI and prediction of response of primary and metastatic liver tumors to radioembolization with Y-90 glass microspheres"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0966-9988","authenticated-orcid":false,"given":"Burak","family":"Demir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cigdem","family":"Soydal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuriye Ozlem","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre Can","family":"Celebioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sad\u0131k","family":"Bilgic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Digdem","family":"Kuru Oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atilla Halil","family":"Elhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kemal Metin","family":"Kir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"1974_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1974_CR2","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1177\/1535370216658144","volume":"241","author":"AM Clark","year":"2016","unstructured":"Clark AM, Ma B, Taylor DL, Griffith L, Wells A. Liver metastases: Microenvironments and ex-vivo models. Exp Biol Med (Maywood). 2016;241:1639\u201352. https:\/\/doi.org\/10.1177\/1535370216658144.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1974_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, et al. BCLC strategy for prognosis prediction and treatment recommendation. the 2022 update. J Hepatol. 2022;76:681\u201393.","journal-title":"J Hepatol"},{"key":"1974_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"M Weber","year":"2022","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. 2022 EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nuclear Med Mol Imaging. 2022;49:5. https:\/\/doi.org\/10.1007\/s00259-021-05600-z.","journal-title":"Eur J Nuclear Med Mol Imaging"},{"key":"1974_CR5","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.jvir.2023.08.031","volume":"34","author":"PW Doyle","year":"2023","unstructured":"Doyle PW, Workman CS, Shah N, McGonigle TW, Grice JV, Huang S, et al. Predictive partition dosimetry and outcomes after yttrium-90 resin microsphere radioembolization of colorectal cancer metastatic to the liver: a retrospective analysis. J Vasc Interv Radiol. 2023;34:2138\u201346.","journal-title":"J Vasc Interv Radiol"},{"key":"1974_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40658-021-00394-3","volume":"8","author":"C Chiesa","year":"2021","unstructured":"Chiesa C, Sjogreen-Gleisner K, Walrand S, Strigari L, Flux G, Gear J, et al. EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Phys. 2021;8:1\u201344. https:\/\/doi.org\/10.1186\/s40658-021-00394-3.","journal-title":"EJNMMI Phys"},{"key":"1974_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12149-023-01890-5","volume":"38","author":"N Noipinit","year":"2024","unstructured":"Noipinit N, Sukprakun C, Siricharoen P, Khamwan K. Comparison of absorbed doses to the tumoral and non-tumoral liver in HCC patients undergoing 99mTc-MAA and 90Y-microspheres radioembolization. Ann Nucl Med. 2024;38:210\u20138.","journal-title":"Ann Nucl Med"},{"key":"1974_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-3-57","volume":"3","author":"YH Kao","year":"2013","unstructured":"Kao YH, Steinberg JD, Tay YS, Lim GKY, Yan J, Townsend DW, et al. Post-radioembolization yttrium-90 PET\/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres. EJNMMI Res. 2013;3:1\u201327. https:\/\/doi.org\/10.1186\/2191-219X-3-57.","journal-title":"EJNMMI Res"},{"key":"1974_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0055742","volume":"8","author":"M Elschot","year":"2013","unstructured":"Elschot M, Vermolen BJ, Lam MGEH, de Keizer B, van den Bosch MAAJ, de Jong HWAM. Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization. PLoS ONE. 2013;8: e55742.","journal-title":"PLoS ONE"},{"key":"1974_CR10","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2967\/jnumed.116.173104","volume":"57","author":"S Gnesin","year":"2016","unstructured":"Gnesin S, Canetti L, Adib S, Cherbuin N, Monteiro MS, Bize P, et al. Partition model-based 99mTc-MAA SPECT\/CT predictive dosimetry compared with 90Y TOF PET\/CT posttreatment dosimetry in radioembolization of hepatocellular carcinoma: a quantitative agreement comparison. J Nucl Med. 2016;57:1672\u20138.","journal-title":"J Nucl Med"},{"key":"1974_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1007\/s00259-019-04465-7","volume":"47","author":"A Jadoul","year":"2020","unstructured":"Jadoul A, Bernard C, Lovinfosse P, G\u00e9rard L, Lilet H, Cornet O, et al. Comparative dosimetry between 99mTc-MAA SPECT\/CT and 90Y PET\/CT in primary and metastatic liver tumors. Eur J Nucl Med Mol Imaging. 2020;47:828\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1974_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejmp.2019.05.025","volume":"64","author":"E Richetta","year":"2019","unstructured":"Richetta E, Pasquino M, Poli M, Cutaia C, Valero C, Tabone M, et al. PET-CT post therapy dosimetry in radioembolization with resin 90Y microspheres: Comparison with pre-treatment SPECT-CT 99mTc-MAA results. Phys Med. 2019;64:16\u201323.","journal-title":"Phys Med"},{"key":"1974_CR13","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.120.255745","volume":"62","author":"AA Alsultan","year":"2021","unstructured":"Alsultan AA, van Roekel C, Barentsz MW, Smits MLJ, Kunnen B, Koopman M, et al. Dose-response and dose-toxicity relationships for glass 90Y radioembolization in patients with liver metastases from colorectal cancer. J Nuclear Med. 2021;62:1616.","journal-title":"J Nuclear Med"},{"key":"1974_CR14","unstructured":"Simplicit90y Dosimetry Planning Software | Read more [Internet]. [cited 2024 Jul 1]. Available from: https:\/\/www.mirada-medical.com\/interventional-radiology"},{"key":"1974_CR15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.ejrad.2016.03.029","volume":"85","author":"W Shady","year":"2016","unstructured":"Shady W, Kishore S, Gavane S, Do RK, Osborne JR, Ulaner GA, et al. Metabolic tumor volume and total lesion glycolysis on FDG-PET\/CT can predict overall survival after (90)Y radioembolization of colorectal liver metastases: a comparison with SUVmax, SUVpeak, and RECIST 10. Eur J Radiol. 2016;85:1224\u201331.","journal-title":"Eur J Radiol"},{"key":"1974_CR16","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2967\/jnumed.115.165613","volume":"57","author":"M Michl","year":"2016","unstructured":"Michl M, Lehner S, Paprottka PM, Ilhan H, Bartenstein P, Heinemann V, et al. Use of PERCIST for prediction of progression-free and overall survival after radioembolization for liver metastases from pancreatic cancer. J Nuclear Med. 2016;57:355\u201360.","journal-title":"J Nuclear Med"},{"key":"1974_CR17","doi-asserted-by":"publisher","DOI":"10.21105\/joss.02445","author":"D L\u00fcdecke","year":"2020","unstructured":"L\u00fcdecke D, Ben-Shachar M, Patil I, Makowski D. Extracting, computing and exploring the parameters of statistical models using R. JOSS. 2020. https:\/\/doi.org\/10.21105\/joss.02445.","journal-title":"JOSS"},{"key":"1974_CR18","unstructured":"Gallucci M. Model goodness of fit in GAMLj [Internet]. 2020: Available from: https:\/\/gamlj.github.io\/details_goodness.html"},{"key":"1974_CR19","unstructured":"Gallucci M. GAMLj: General analyses for linear models [Internet]. 2019: Available from: https:\/\/gamlj.github.io\/"},{"key":"1974_CR20","unstructured":"R Core Team. R: A Language and environment for statistical computing [Internet]. 2022: Available from: https:\/\/cran.r-project.org"},{"key":"1974_CR21","unstructured":"The jamovi project. jamovi [Internet]. 2023: Available from: https:\/\/www.jamovi.org"},{"key":"1974_CR22","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E, et al. Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology. 2021;74:2342\u201352.","journal-title":"Hepatology"},{"key":"1974_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, De Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6:17\u201329.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1974_CR24","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00270-015-1285-y","volume":"39","author":"KJ Fowler","year":"2016","unstructured":"Fowler KJ, Maughan NM, Laforest R, Saad NE, Sharma A, Olsen J, et al. PET\/MRI of hepatic 90Y microsphere deposition determines \u0131ndividual tumor response. Cardiovasc Intervent Radiol. 2016;39:855\u201364.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1974_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-018-0222-y","author":"K Kne\u0161aurek","year":"2018","unstructured":"Kne\u0161aurek K, Tuli A, Kim E, Heiba S, Kostakoglu L. Comparison of PET\/CT and PET\/MR imaging and dosimetry of yttrium-90 (90Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with 90Y microspheres. EJNMMI Phys. 2018. https:\/\/doi.org\/10.1186\/s40658-018-0222-y.","journal-title":"EJNMMI Phys"},{"key":"1974_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejrad.2018.10.015","volume":"109","author":"K Kne\u0161aurek","year":"2018","unstructured":"Kne\u0161aurek K, Tuli A, Pasik SD, Heiba S, Kostakoglu L. Quantitative comparison of pre-therapy 99mTc-macroaggregated albumin SPECT\/CT and post-therapy PET\/MR studies of patients who have received intra-arterial radioembolization therapy with 90Y microspheres. Eur J Radiol. 2018;109:57\u201361.","journal-title":"Eur J Radiol"},{"key":"1974_CR27","first-page":"24","volume":"6","author":"A Takahashi","year":"2018","unstructured":"Takahashi A, Himuro K, Baba S, Yamashita Y, Sasaki M. Comparison of TOF-PET and Bremsstrahlung SPECT \u0131mages of Yttrium-90: a Monte Carlo simulation study. Asia Ocean J Nucl Med Biol. 2018;6:24\u201331.","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"1974_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040959","author":"C Roman\u00f2","year":"2022","unstructured":"Roman\u00f2 C, Mazzaglia S, Maccauro M, Spreafico C, Gabutti A, Maffi G, et al. Radioembolization of hepatocellular carcinoma with 90Y glass microspheres: no advantage of voxel dosimetry with respect to mean dose in dose-response analysis with two radiological methods. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14040959.","journal-title":"Cancers (Basel)"},{"key":"1974_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2967\/jnumed.111.094235","volume":"53","author":"E Garin","year":"2012","unstructured":"Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, et al. Dosimetry based on 99mTc-macroaggregated albumin SPECT\/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results. J Nucl Med. 2012;53:255\u201363.","journal-title":"J Nucl Med"},{"key":"1974_CR30","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","volume":"34","author":"A Villalobos","year":"2023","unstructured":"Villalobos A, Arndt L, Cheng B, Dabbous H, Loya M, Majdalany B, et al. Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based microspheres. J Vasc Interv Radiol. 2023;34:1226\u201334.","journal-title":"J Vasc Interv Radiol"},{"key":"1974_CR31","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2174\/1874471016666230608100921","volume":"16","author":"A Milano","year":"2023","unstructured":"Milano A, Capotosti A, Zagaria L, Perotti G, Rizzo A, Longo V, et al. Dose-response analysis in hepatic tumors treated with 90Y-TARE according to a personalized dosimetric workflow: preliminary results. Curr Radiopharm. 2023;16:326\u201336.","journal-title":"Curr Radiopharm"},{"key":"1974_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-022-00879-x","author":"EB Veenstra","year":"2022","unstructured":"Veenstra EB, Ruiter SJS, de Haas RJ, Bokkers RPH, de Jong KP, Noordzij W. Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC. EJNMMI Res. 2022. https:\/\/doi.org\/10.1186\/s13550-022-00879-x.","journal-title":"EJNMMI Res"},{"key":"1974_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/or.2016.5284","volume":"37","author":"E Janowski","year":"2017","unstructured":"Janowski E, Timofeeva O, Chasovskikh S, Goldberg M, Kim A, Banovac F, et al. Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: clinical and ccfDNA studies. Oncol Rep. 2017;37:57\u201365.","journal-title":"Oncol Rep"},{"key":"1974_CR34","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.jvir.2015.05.032","volume":"26","author":"SJ Lahti","year":"2015","unstructured":"Lahti SJ, Xing M, Zhang D, Lee JJ, Magnetta MJ, Kim HS. KRAS status as an \u0131ndependent prognostic factor for survival after Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastases. J Vasc Interv Radiol. 2015;26:1102\u201311.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-01974-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01974-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:09:52Z","timestamp":1736302192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-01974-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1974"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-01974-w","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ankara University (21.04.2022\/No. \u013004-203\u201322).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants prospectively included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}